|Histone H4 K12, 16Ac K20Me2 Peptide Description: |
A synthetic peptide derived from human histone H4, amino acids 11-27, acetylated at lysine 12 and lysine 16 and dimethylated at lysine 20. The alpha-amino group on the N-terminus is acetylated, with a C-terminal PEG spacer containing a biotin moiety.
|Histone H4 K12, 16Ac K20Me2 Peptide Formulation: |
50 µg of lyophilized powder.
|Histone H4 K12, 16Ac K20Me2 Peptide Sequence: |
|Histone H4 K12, 16Ac K20Me2 Molec. Weight: 2516 Da. |
|Histone H4 K12, 16Ac K20Me2 Purity: >98% as judged by HPLC and mass spectrometry. |
|Histone H4 K12, 16Ac K20Me2 Storage and Stability: Lyophilized peptides are stable for 2 years at -20°C from date of shipment. Peptides in solution are stable for 6 months at -20°C. Reconstitute with sterile distilled water and aliquot to avoid repeated freezing and thawing. |
|Histone H4 K12, 16Ac K20Me2 Quality Control: Peptide purified by reversed-phase HPLC and analyzed using MALD-TOF mass spectrometry and analytical RP-HPLC. || |
Mass Spec Data: MALDI-TOF mass spectrometry was used to analyze histone H4 K12, 16Ac K20Me2 peptide for identity and homogeneity.
HPLC Data: Reversed-phase analytical HPLC chromatogram of purified histone H4 K12, 16Ac K20Me2 peptide.